Veeda announces the appointment of Mr. Venu Madhav as the new COO

Veeda Clinical Research announced the appointment of Mr. Venu Madhav as the new Chief Operating Officer of its unit in India.

Ahmedabad, Gujarat, February 25, 2010 /India PRwire/ -- Veeda Clinical Research announced the appointment of Mr. Venu Madhav as the new Chief Operating Officer of its unit in India.

"We are happy to have Venu join the Veeda family and we are sure that with his experience and knowledge he will help to continue Veeda grow in early clinical development and augment our position in the market as leaders in this field", said Binoy Gardi, Group Managing Director, Veeda.

Mr. Venu Madhav is post graduate in pharmacy and having 19 years of experience in diverse areas of clinical research. He has been associated with reputed companies likes Ranbaxy and Sun Pharma especially in the growth period of these organizations. His contribution for the growth of these organizations is noticeable.

Mr. Venu carries rich experience in planning bioequivalence studies from pilot to pivotal stage for generic formulations. He has designed clinical, bioanalytical, pharmacokinetic and statistical aspects of bioavailability and bioequivalence studies. He is credited to have coordinated for more than 450 pilot and pivotal biostudies for conventional formulations and extended release formulations.

He has held the responsibility for developing complex bioanalytical methods for hormonal and peptide products apart for the effective utilization of 250 methods. He has also handled more than 150 pilot and 300 pivotal bioanalytical projects with GLP compliance. Pivotal biostudies were audited by most of the regulatory inspections and subsequent approval.

During his tenure Mr. Venu has also handled pharmacokinetic and statistical evaluation of data for ANDA/ NDA submissions. He has conducted a workshop as well on 'Bioequivalence Studies' for Bahrain and Oman regulatory officials.

His last stint has been with Sun Pharma Advanced Research Center (SPARC) Baroda as Sr. General Manager - Pharmacokinetic Department.

Notes to Editor

Veeda Clinical Research® is a leading CRO which brings together over 20 years of clinical research expertise to deliver a unique service offering which combines the quality and experience of the West with the intellectual ability and tireless work ethic of the East.

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


Veeda Clinical Research recent press release(s)


Veeda Oncology Announces $8.4 million in New Business

Veeda Oncology®, a full service Oncology CRO with facilities in North America, Europe and India, has been awarded over $8.4 million of new clinical research programs over the past 30 days.

Apurva Shah on his being selected as the Chairman of ACRO

In January 2010, the Second Executive Council has been elected for the next 2 years. Our mission is to make ACRO an apex and active body for the Clinical Research industry in India

Veeda Clinical Research demonstrates its Potential in Experimental Medicine

Of late, many observers have been waiting to see how good the Indian CROs are at performing in the Phase I and early clinical development world

Minister for Health and Tourism of Gujarat state visited Veeda's unit in MPUH

Minister for Health and Tourism of Gujarat state visited Veeda's unit in MPUH during the inauguration ceremony of the Uro-Oncology conference

Veeda celebrates 5 years of success

On 29th Jannuary 2010 Veeda Clinical Research celebrated its 5th Annual Day